Pete Taft, PharmApprove Founder and CEO, has been asked to co-chair a first-of-its-kind conference focused on the increasingly-critical FDA Advisory Committee process. The conference, organized by the Center For Business Intelligence (CBI), brings together a host of influential voices in the field of regulatory affairs to examine the changing rules, regulations and best practices for preparing to deliver sound arguments for a drug or device’s approval at FDA Advisory Committee hearings. It will be held on April 26-27 in Alexandria, VA.

Register for the conference now or read the entire press release to learn more.

Pete Taft interviews Douglas Greene, Senior Vice President and Senior Scientific Advisor for Sanofi-Aventis about the changing landscape of FDA Advisory Committee hearings.